Integrated DNA Technologies (IDT) has announced a suite of next generation sequencing (NGS) innovations that aim to tackle longstanding bottlenecks in library preparation, targeted enrichment, and whole genome analysis.
The newly announced portfolio—which includes the DNA EZ v2 Library Preparation Kit, the xGen Exome v2 Hyb Spike-In Panel, an expanded set of 1,536 Full-Length Unique Dual Index (UDI) Adapters, and the enhanced whole genome sequencing (eWGS) system—is designed to simplify NGS workflows, sharpen critical variant identification, and support broad biomarker discovery across targeted and whole genome applications.
IDT’s NGS roadmap reflects a multi‑omics strategy built on differentiated chemistries and algorithms that support DNA, methylation, and RNA sequencing workflows. Powered by IDT’s synthesis platform and enzyme engineering expertise, the portfolio advances diverse biomarker modalities essential for translational oncology research.
A key highlight is IDT’s advanced fragmentation module, engineered to reduce GCrelated bias and minimize fragmentation-induced artifacts—two longstanding challenges in library construction. This tunable fragmentation capability supports seamless transitions between whole genome and targeted sequencing, enabling researchers to unify workflows across tumor-informed profiling and minimal residual disease (MRD) applications.
The Exome v2 Hyb Spike-In Panel introduces broadened and modernized genomic coverage aligned with major databases to strengthen pathogenic variant classification and mitigate the risk of misinterpretation as standards evolve. It is designed to integrate effortlessly into IDT’s existing hybrid capture ecosystem and Exome Hyb Panel v2.
The streamlined eWGS system delivers full genome breadth paired with enriched coverage of associated genomic regions of interest—all within a single, streamlined assay.
